Paradigm Pulse cover art

Paradigm Pulse

Paradigm Pulse

By: Paradigm Medical Communications LLC
Listen for free

This Season's Biggest Deal | £0.99/mo for 3 months + £10 Audible bonus

£5.99/mo after 3 months - terms apply. Cancel monthly
Listen to audio from accredited CME activities from Paradigm Medical Communications, featuring expert faculty discussions and the latest clinical insights. Visit the link in each episode description to access the full activity and claim CME credit.© 2026 Paradigm Medical Communications, LLC Science
Episodes
  • Second-Generation Retinal Care: Finding Your Footing Among Shifting Practice Paradigms - Part 3: Dosing for Durability Without Compromising Outcomes
    Oct 27 2026

    Please CLICK HERE, or paste the following URL into your browser, (https://activities.paradigmmc.com/14743P) to view the full CME activity and claim credit for your participation.

    • (00:00) - Introduction
    • (06:20) - Dosing Intervals in Treatment-Naïve Patients
    • (09:18) - Dosing Intervals in Previously Treated Patients
    • (16:10) - Defining “Disease Control”
    • (20:51) - Personalized Treatment Intervals and Home OCT
    • (27:46) - Summary

    Same diagnosis, multiple treatment options, vastly different responses. In the era of second-generation therapy, which treatment plans best minimize injection burden while preserving vision?

    In this third and final episode, Dr Goldberg and Dr Weng address the ins and outs of dosing second-generation therapy, including the loading phase and how to individualize injection intervals.

    TRANSCRIPT

    Show More Show Less
    29 mins
  • Second-Generation Retinal Care: Finding Your Footing Among Shifting Practice Paradigms - Part 2: Progress in Biomarker-Based Care
    Oct 27 2026

    Please CLICK HERE, or paste the following URL into your browser, (https://activities.paradigmmc.com/14742P) to view the full CME activity and claim credit for your participation.

    • (00:00) - Introduction
    • (06:23) - Dual Inhibition in Neovascular Retinal Disease
    • (09:37) - Imaging Biomarkers of nAMD
    • (17:50) - Imaging Biomarkers of DME
    • (25:27) - Imaging Tools
    • (27:20) - Summary

    Same diagnosis, multiple treatment options, vastly different responses. In the era of second-generation therapy, which treatment plans best minimize injection burden while preserving vision?

    In part 2 of this 3-part podcast series, Dr Weng and Dr Goldberg dive deeper into imaging. What findings help you choose one therapy over another now that second-generation options are available?

    TRANSCRIPT

    Show More Show Less
    30 mins
  • Second-Generation Retinal Care: Finding Your Footing Among Shifting Practice Paradigms - Part 1: Who’s the Right Patient?
    Oct 27 2026

    Please CLICK HERE, or paste the following URL into your browser, (https://activities.paradigmmc.com/14741P) to view the full CME activity and claim credit for your participation.

    • (00:00) - Introduction
    • (01:40) - Second-Generation Therapy in Treatment-Naïve Patients
    • (10:17) - Treatment Durability in the Real World
    • (20:07) - DRCR.net Protocol AO
    • (21:59) - Considering a Therapy Switch
    • (28:12) - Summary

    Same diagnosis, multiple treatment options, vastly different responses. In the era of second-generation therapy, which treatment plans best minimize injection burden while preserving vision?

    In part 1 of this 3-part podcast series, Dr Goldberg and Dr Weng get to the crux of whom do we start on, and whom do we switch to, second-generation therapy. What flips the switch?

    TRANSCRIPT

    Show More Show Less
    30 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet